← Leaderboards
Gebhard Wagener
Columbia University Health Sciences
$1,679,055
Attributed
$5,942,498
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,942,498 · 4
By mechanism
UH3$2,694,009 · 1
R01$2,101,922 · 1
UG3$927,319 · 1
R21$219,248 · 1
Top collaborators
- Sandra D. Comer3 shared
- Jeanine M D'Armiento3 shared
- Alonso Guedes3 shared
- Lynne L. Johnson3 shared
- Howard Levin3 shared
- Roderic G Eckenhoff1 shared
- Neil Malhotra1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Jeanine M D'armiento$14,757,679
- Alexander D. Klose$7,357,783
- Richard P Sloan$20,573,768
Others in their field
Top investigators on “Pre-Clinical Model”
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,997,443
- David Heimbrook · Leidos Biomedical Research, Inc.$96,812,185
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,451,222
- David M Anderson · University Of Washington$94,243,251
- Ronald B Corley · Boston University Medical Campus$80,765,880
Research focus
Pre-Clinical ModelSafetySymptomsResearch Clinical TestingUnited StatesPre-ClinicalEpidemicElectronicsEvaluationDiagnosisElectrodesApneaClinicApplications GrantsDesign VerificationDoseChest Wall StructureBreathingDesignCause Of DeathCessation Of LifeDevicesClinical TrialsCollaborations
Grant awards (7)
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$2,544,126
UH3 · FY2025 · DA
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$149,883
UH3 · FY2025 · DA
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$927,319
UG3 · FY2023 · DA
Relationship between CNS Tau burden and perioperative neurocognitive disorder$219,248
R21 · FY2021 · AG
In vivo imaging of destructive processes in COPD$696,374
R01 · FY2018 · HL
In vivo imaging of destructive processes in COPD$702,774
R01 · FY2017 · HL
In vivo imaging of destructive processes in COPD$702,774
R01 · FY2016 · HL